Bafna Pharmaceuticals Ltd

📈 Bafna Pharmaceuticals Clarifies Recent Share Price Movement

• Issued clarification letter to BSE and NSE on April 15, 2026

• Responded to specific exchange references (NSE: NSE/CM/Surveillance/16817, BSE: L/SURV/ONL/PV/APJ/2026-2027/3719)

• Attributed share price movement to market-driven factors and general market conditions

• Confirmed no undisclosed information or company control over price fluctuations

• Assured compliance with SEBI disclosure requirements under Regulation 30

• Signed by Mohanachandran A, Company Secretary & Compliance Officer